Abstract
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Yamid F. Astudillo-Yandi, Stephany Barbosa-Balaguera, Sebastián Ayala-Zapata, Álvaro Herrera-Escandón
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
10.1093/eurheartj/ehab368 · 2021
Global burden of heart failure: a comprehensive and updated review of epidemiology
10.1093/cvr/cvac013 · 2022
Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003
10.1161/circulationaha.108.812172 · 2009
Understanding the epidemic of heart failure: past, present, and future
10.1007/s11897-014-0220-x · 2014
European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions
10.1002/ejhf.566 · 2016
EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients
10.1093/eurheartj/ehl193 · 2006
Colombian Heart Failure Registry (RECOLFACA): results
2021
American Registry of Ambulatory or Acutely Decompensated Heart Failure (AMERICCAASS Registry): first 1000 patients
10.1002/clc.24182 · 2024
Decompensated heart failure in a single center of a Latin American country: findings from the first 1595 cases in the ICARUS registry
2024
Burden of heart failure in Latin America: a systematic review and meta-analysis
2016
The reality of heart failure in Latin America
10.1016/j.jacc.2013.06.013 · 2013
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
10.1093/eurheartj/ehad195 · 2023
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
2022
Empagliflozin in heart failure with a preserved ejection fraction
10.1056/nejmoa2107038 · 2021
Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction
10.1056/nejmoa2206286 · 2022
Clinical assessment identifies hemodynamic profiles that predict outcomes in patients admitted with heart failure
10.1016/s0735-1097(03)00309-7 · 2003
Comorbidity in heart failure: results of the Spanish RICA Registry
10.1093/qjmed/hcu127 · 2014
Epidemiology of heart failure with preserved ejection fraction
10.1038/nrcardio.2017.65 · 2017
Dapagliflozin in patients with heart failure and reduced ejection fraction
10.1056/nejmoa1911303 · 2019
Cardiovascular and renal outcomes with empagliflozin in heart failure
10.1056/nejmoa2022190 · 2020
The STROBE Statement: guidelines for reporting observational studies
10.1016/j.ijsu.2014.07.013 · 2014
Unresolved referenced work
1993
No additional external references are available.